Amgen Inc. buy Royal Bank of Canada
Start price
07.02.24
/
50%
€281.00
Target price
07.02.25
€305.58
Performance (%)
2.92%
Price
20:02
€285.05
Summary
This prediction is currently active. With a performance of 2.92%, the BUY prediction by Royal_Bank_of_Canada for Amgen Inc. is trending in the right direction. Dividends of €4.16 are taken into consideration when calculating the performance. This prediction currently runs until 07.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amgen Inc. | -2.066% | -2.066% |
iShares Core DAX® | 1.175% | -0.931% |
iShares Nasdaq 100 | 1.232% | 9.715% |
iShares Nikkei 225® | 1.563% | 3.040% |
iShares S&P 500 | 0.034% | 5.962% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Royal Bank of Canada from $303.00 to $329.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat